Literature DB >> 17686195

Part II. Analysis of data gaps pertaining to Shigella infections in low and medium human development index countries, 1984-2005.

P K Ram1, J A Crump, S K Gupta, M A Miller, E D Mintz.   

Abstract

The global incidence of Shigella infection has been estimated at 80-165 million episodes annually, with 99% of episodes occurring in the developing world. To identify contemporary gaps in the understanding of the global epidemiology of shigellosis, we conducted a review of the English-language scientific literature from 1984 to 2005, restricting the search to low and medium human development countries. Our review yielded 11 population-based studies of Shigella burden from seven countries. No population-based studies have been conducted in sub-Saharan Africa or in low human development countries. In studies done in all age groups, Shigella incidence varied from 0.6 to 107 episodes/1000 person-years. S. flexneri was the most commonly detected subgroup in the majority of studies. Case-fatality rates ranged from 0% to 2.6% in population-based studies and from 0% to 21% in facility-based studies. This review highlights the large gaps in data on the burden of Shigella infections for low human development index countries and, more specifically, for sub-Saharan Africa.

Entities:  

Mesh:

Year:  2007        PMID: 17686195      PMCID: PMC2870860          DOI: 10.1017/S0950268807009351

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  172 in total

1.  The spread of Shigella dysenteriae type I in Africa.

Authors:  D F Wittenberg
Journal:  Jpn J Med Sci Biol       Date:  1998

2.  Detection of Shigellae from stools of dysentery patients by culture and polymerase chain reaction techniques.

Authors:  M S Islam; M S Hossain; M K Hasan; M M Rahman; G Fuchs; D Mahalanabis; A H Baqui; M J Albert
Journal:  J Diarrhoeal Dis Res       Date:  1998-12

3.  Escherichia coli in patients with acute gastroenteritis in Lagos, Nigeria.

Authors:  K O Akinyemi; A O Oyefolu; B Opere; V A Otunba-Payne; A O Oworu
Journal:  East Afr Med J       Date:  1998-09

4.  Shigella antibiotic resistance in central Turkey: comparison of the years 1987-1994 and 1995-2002.

Authors:  Elif N Ozmert; Bahar Göktürk; Kadriye Yurdakök; S Songül Yalçin; Deniz Gür
Journal:  J Pediatr Gastroenterol Nutr       Date:  2005-03       Impact factor: 2.839

5.  Case-control study of enteropathogens associated with childhood diarrhea in Dhaka, Bangladesh.

Authors:  M J Albert; A S Faruque; S M Faruque; R B Sack; D Mahalanabis
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

6.  Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.

Authors:  K L Kotloff; J P Winickoff; B Ivanoff; J D Clemens; D L Swerdlow; P J Sansonetti; G K Adak; M M Levine
Journal:  Bull World Health Organ       Date:  1999       Impact factor: 9.408

7.  Identification of Shigella flexneri subserotype 1c in rural Egypt.

Authors:  A El-Gendy; N El-Ghorab; E M Lane; R A Elyazeed; N I Carlin; M M Mitry; B A Kay; S J Savarino; L F Peruski
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

8.  Central nervous system manifestations of childhood shigellosis: prevalence, risk factors, and outcome.

Authors:  W A Khan; U Dhar; M A Salam; J K Griffiths; W Rand; M L Bennish
Journal:  Pediatrics       Date:  1999-02       Impact factor: 7.124

9.  Aetiological, clinical and epidemiological characteristics of a seasonal peak of diarrhoea in Dhaka, Bangladesh.

Authors:  A S Faruque; M A Salam; S M Faruque; G J Fuchs
Journal:  Scand J Infect Dis       Date:  1998

10.  The detection of enteropathogens in acute diarrhea in a family cohort population in rural Egypt.

Authors:  A M Zaki; H L DuPont; M A el Alamy; R R Arafat; K Amin; M M Awad; L Bassiouni; I Z Imam; G S el Malih; A el Marsafie
Journal:  Am J Trop Med Hyg       Date:  1986-09       Impact factor: 2.345

View more
  35 in total

1.  Global epidemiology of infections due to Shigella, Salmonella serotype Typhi, and enterotoxigenic Escherichia coli.

Authors:  M A Miller; J Sentz; M A Rabaa; E D Mintz
Journal:  Epidemiol Infect       Date:  2008-04       Impact factor: 2.451

Review 2.  Enteric infections, diarrhea, and their impact on function and development.

Authors:  William A Petri; Mark Miller; Henry J Binder; Myron M Levine; Rebecca Dillingham; Richard L Guerrant
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

3.  Identification and characterization of CTX-M-producing Shigella isolates in the United States.

Authors:  Jason P Folster; Gary Pecic; Amy Krueger; Regan Rickert; Karen Burger; Alessandra Carattoli; Jean M Whichard
Journal:  Antimicrob Agents Chemother       Date:  2010-03-08       Impact factor: 5.191

4.  Decreased susceptibility to ciprofloxacin among Shigella isolates in the United States, 2006 to 2009.

Authors:  Jason P Folster; Gary Pecic; Anna Bowen; Regan Rickert; Alessandra Carattoli; Jean M Whichard
Journal:  Antimicrob Agents Chemother       Date:  2011-01-10       Impact factor: 5.191

5.  Evaluation of the Safety, Tolerability, and Immunogenicity of an Oral, Inactivated Whole-Cell Shigella flexneri 2a Vaccine in Healthy Adult Subjects.

Authors:  Subhra Chakraborty; Clayton Harro; Barbara DeNearing; Jay Bream; Nicole Bauers; Len Dally; Jorge Flores; Lillian Van de Verg; David A Sack; Richard Walker
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

6.  A changing picture of shigellosis in southern Vietnam: shifting species dominance, antimicrobial susceptibility and clinical presentation.

Authors:  Ha Vinh; Nguyen Thi Khanh Nhu; Tran Vu Thieu Nga; Pham Thanh Duy; James I Campbell; Nguyen Van Minh Hoang; Maciej F Boni; Phan Vu Tra My; Christopher Parry; Tran Thi Thu Nga; Pham Van Minh; Cao Thu Thuy; To Song Diep; Le Thi Phuong; Mai Thu Chinh; Ha Thi Loan; Nguyen Thi Hong Tham; Mai Ngoc Lanh; Bui Li Mong; Vo Thi Cuc Anh; Phan Van Be Bay; Nguyen Van Vinh Chau; Jeremy Farrar; Stephen Baker
Journal:  BMC Infect Dis       Date:  2009-12-15       Impact factor: 3.090

7.  Circulating Gut-Homing (α4β7+) Plasmablast Responses against Shigella Surface Protein Antigens among Hospitalized Patients with Diarrhea.

Authors:  Anuradha Sinha; Ayan Dey; Giulietta Saletti; Pradip Samanta; Partha Sarathi Chakraborty; M K Bhattacharya; Santanu Ghosh; T Ramamurthy; Jae-Ouk Kim; Jae Seung Yang; Dong Wook Kim; Cecil Czerkinsky; Ranjan K Nandy
Journal:  Clin Vaccine Immunol       Date:  2016-07-05

8.  Influence of Shigella flexneri 2a O Antigen Acetylation on Its Bacteriophage Sf6 Receptor Activity and Bacterial Interaction with Human Cells.

Authors:  Min Yan Teh; Axel Furevi; Göran Widmalm; Renato Morona
Journal:  J Bacteriol       Date:  2020-11-19       Impact factor: 3.490

9.  A unified approach to molecular epidemiology investigations: tools and patterns in California as a case study for endemic shigellosis.

Authors:  Sawsan Al-Nimri; Woutrina A Miller; Barbara A Byrne; Gerry Guibert; Lily Chen
Journal:  BMC Infect Dis       Date:  2009-11-24       Impact factor: 3.090

10.  Increasing clinical resistance rate of Shigella sonnei to cefotaxime in Jiangsu Province, China, between 2012 and 2015.

Authors:  Huimin Qian; Guoye Liu; Yin Chen; Ping Ma; Xiaoxiao Kong; Lu Zhou; Jie Hong; Changjun Bao; Bing Gu
Journal:  Ann Transl Med       Date:  2018-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.